Mitral Valve Disease
The ACTIVE Trial is a prospective, randomized, multicenter trial. Patients with clinically significant functional mitral regurgitation will be randomized 2:1 to receive either transcatheter mitral valve repair with the Edwards Cardioband System plus guideline directed medical therapy (GDMT) or GDMT alone. Patients will be seen for follow-up visits at discharge, 30 days, 6 months, and annually through 5 years.
Principal Investigator: Robert L. Smith, II, MD
Locations: Baylor Scott & White The Heart Hospital – Plano
Sponsor: Edwards Lifesciences
IRB Number: 017-150
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: Participating may change your care
Brittany Zingler, RN469.814.4737Brittany.Zingler@BSWHealth.org
Necole Kell, RN469.814.4871Necole.Kell@BSWHealth.org
Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Scott & White Health's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Scott & White Health.